Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "Sanofi"
showing the first 40- AVENTISSC TO-T/A · 2004-04-20Read the filing on SEC.gov →
- NEUROCRINE BIOSCIENCES INC (NBIX)10-K · 2026-02-11Read the filing on SEC.gov →
- Cancer Prevention Pharmaceuticals, Inc.S-1 · 2015-12-23Read the filing on SEC.gov →
- Icagen, Inc.8-K · 2016-07-19Read the filing on SEC.gov →
- AVENTISSC TO-T/A · 2004-07-29Read the filing on SEC.gov →
- SELECTA BIOSCIENCES INC (RNAC)DRS/A · 2016-03-18Read the filing on SEC.gov →
- Regulus Therapeutics Inc. (RGLS)10-K · 2019-03-18Read the filing on SEC.gov →
- SANOFI SYNTHELABO SAPOS AM · 2004-05-05Read the filing on SEC.gov →
- SANOFI SYNTHELABO SA6-K · 2004-01-26Read the filing on SEC.gov →
- AVENTISSC 14D9/A · 2004-06-01Read the filing on SEC.gov →
- AVENTISSC TO-T/A · 2004-09-07Read the filing on SEC.gov →
- SCYNEXIS INC (SCYX)DRS/A · 2014-01-29Read the filing on SEC.gov →
- ARDELYX, INC. (ARDX)DRS · 2014-04-11Read the filing on SEC.gov →
- Cancer Prevention Pharmaceuticals, Inc.DRS · 2015-09-04Read the filing on SEC.gov →
- ADMA BIOLOGICS, INC. (ADMA)10-K · 2018-03-29Read the filing on SEC.gov →
- ARDELYX, INC. (ARDX)S-1 · 2014-05-19Read the filing on SEC.gov →
- Enumeral Biomedical Holdings, Inc.8-K/A · 2014-10-31Read the filing on SEC.gov →
- AVENTISSC TO-T · 2004-04-12Read the filing on SEC.gov →
- AVENTIS425 · 2004-01-26Read the filing on SEC.gov →
- Sanofi6-K · 2016-06-13Read the filing on SEC.gov →
- ARDELYX, INC. (ARDX)S-1/A · 2014-06-05Read the filing on SEC.gov →
- GENZYME CORPSC 14D9/A · 2011-01-20Read the filing on SEC.gov →
- GENZYME CORPSC 14D9/A · 2010-10-20Read the filing on SEC.gov →
- SANOFI SYNTHELABO SAF-4/A · 2004-03-12Read the filing on SEC.gov →
- Principia Biopharma Inc.SC TO-C · 2020-08-18Read the filing on SEC.gov →
- VIVUS INC10-K · 2014-02-28Read the filing on SEC.gov →
- AVENTISSC 14D9 · 2004-03-12Read the filing on SEC.gov →
- AVENTISSC TO-T/A · 2004-09-16Read the filing on SEC.gov →
- DarioHealth Corp. (DRIO)10-Q · 2023-08-10Read the filing on SEC.gov →
- AVENTISSC TO-T/A · 2004-09-03Read the filing on SEC.gov →
- PIERIS PHARMACEUTICALS, INC. (PIRS)10-K · 2015-03-30Read the filing on SEC.gov →
- AVENTISSC TO-T/A · 2004-08-02Read the filing on SEC.gov →
- Nurix Therapeutics, Inc. (NRIX)DRS · 2020-05-05Read the filing on SEC.gov →
- Khosla Ventures Acquisition Co.S-4/A · 2021-10-20Read the filing on SEC.gov →
- HORIZON PHARMA, INC.S-1/A · 2010-10-21Read the filing on SEC.gov →
- Kymera Therapeutics, Inc. (KYMR)S-1 · 2020-07-31Read the filing on SEC.gov →
- SANOFI SYNTHELABO SAPOS AM · 2004-05-05Read the filing on SEC.gov →
- Provention Bio, Inc.8-K · 2022-10-06Read the filing on SEC.gov →
- MEDIVATION, INC.DFAN14A · 2016-06-13Read the filing on SEC.gov →
- KALOBIOS PHARMACEUTICALS INC10-12G · 2012-06-12Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.